Surgical oncology consultation involves assessing patients with suspected or confirmed cancer to determine whether surgery is appropriate. The specialist reviews medical history, imaging, biopsy findings and cancer stage before recommending treatment. Surgical planning may involve collaboration with medical oncologists, radiation oncologists and other healthcare professionals.
Gastrointestinal cancer surgery involves removing malignant tumours affecting digestive organs such as the stomach, intestines and rectum. The surgical approach depends on cancer location, stage and surrounding tissue involvement. Selected patients may require chemotherapy or radiation therapy before or after surgery as part of comprehensive treatment.
Colorectal cancer surgery aims to remove malignant tumours from the colon or rectum along with appropriate surrounding tissues and lymph nodes. Depending on the location and extent of disease, surgery may be performed through open, laparoscopic or robotic techniques. Additional treatment may be recommended according to cancer staging.
Breast cancer surgery may involve removing the tumour while preserving the breast or performing mastectomy when clinically indicated. Treatment planning considers tumour size, location, cancer stage and patient preferences. Breast reconstruction or oncoplastic techniques may also be considered in selected patients following multidisciplinary assessment.
Gynaecological cancer surgery includes procedures used to treat selected malignancies affecting the ovaries, uterus, cervix and other reproductive organs. The extent of surgery depends on cancer type, stage and reproductive considerations. Treatment may involve tumour removal, lymph node assessment and coordination with other oncology specialists.
Ovarian cancer surgery aims to remove visible cancerous tissue and establish accurate disease staging. Depending on cancer spread and patient condition, the operation may involve removal of reproductive organs and affected abdominal tissues. Chemotherapy is often incorporated into the overall treatment plan when clinically indicated.
Cytoreductive surgery is performed to remove as much visible cancerous tissue as safely possible, particularly for selected cancers involving the abdominal cavity. It may be combined with other treatments such as chemotherapy. Eligibility depends on disease distribution, general health and the likelihood of achieving meaningful tumour removal.
HIPEC is a specialised treatment in which heated chemotherapy is circulated within the abdominal cavity, usually after cytoreductive surgery. It may be considered for selected peritoneal surface malignancies. Its use depends on cancer type, extent of disease, available evidence and careful assessment by an experienced multidisciplinary team.
Minimally invasive cancer surgery uses laparoscopic or robotic instruments to perform selected operations through smaller incisions. Potential benefits may include reduced postoperative discomfort and shorter hospital recovery for suitable patients. The technique must allow appropriate cancer removal and is selected according to tumour characteristics and surgical complexity.
Robotic cancer surgery uses computer-assisted instruments controlled by the surgeon during selected oncological procedures. The technology provides enhanced instrument movement and visualisation in confined anatomical spaces. Suitability depends on cancer type, location, surgical requirements and access to the necessary specialised facilities.
Head and neck cancer surgery involves removing selected tumours affecting structures such as the oral cavity, throat and neck. Treatment may require evaluation of lymph nodes and reconstruction of affected tissues. Surgical planning considers cancer stage, speech, swallowing and other important functional outcomes.
Genitourinary cancer surgery includes surgical treatment for selected malignancies affecting the kidneys, bladder and other urinary or reproductive organs. The appropriate operation depends on tumour location and stage. Management may require collaboration between surgical oncologists, urologists, medical oncologists and radiation specialists.
Soft tissue sarcomas are uncommon cancers arising from tissues such as muscle, fat and connective tissue. Surgery may be recommended to remove the tumour with an appropriate margin of surrounding tissue. Treatment planning depends on tumour size, grade, location and involvement of nearby structures.
Cancer staging helps determine the extent of disease and guides decisions about surgery and other treatments. Evaluation may involve imaging, biopsy review and multidisciplinary discussion. The resulting plan considers whether cancer can be surgically removed and whether additional therapy is required before or after an operation.